Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice
Lihong He, Wenqiang Sun, Limin Yang, et al.
Virologica Sinica (2022) Vol. 37, Iss. 5, pp. 746-757
Open Access | Times Cited: 14

Showing 14 citing articles:

Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future
Muhammad Bashir Bello, Ahlam Alsaadi, Asif Naeem, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
Hanjin Seo, Leekang Jeon, Jaeyeong Kwon, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 13
Closed Access | Times Cited: 24
Current status of the development of dengue vaccines
Michelle Felicia Lee, Long Chiau Ming, Chit Laa Poh
Vaccine X (2024) Vol. 22, pp. 100604-100604
Open Access | Times Cited: 4
Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates
Kai Yan, Lingjing Mao, Jiaming Lan, et al.
The Journal of Microbiology (2025) Vol. 63, Iss. 2, pp. e2410018-e2410018
Closed Access
Opportunities and challenges of mRNA technologies in development of dengue virus vaccine
Xiaoyang Liu
Frontiers in Immunology (2025) Vol. 16
Open Access
Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications
Kam W. Leong, Seng Kong Tham, Chit Laa Poh
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern
Monika Kumari, Kang-Hao Liang, Shih-Chieh Su, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 714-714
Open Access | Times Cited: 2
An effective pan-serotype dengue vaccine and enhanced control strategies could help in reducing the severe dengue burden in Bangladesh–A perspective
Mohammad Enamul Hoque Kayesh, Humayra Nazneen, Michinori Kohara, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Multitarget Compounds for Neglected Diseases: A Review
Natália Ferreira de Sousa, Gabriela Ribeiro de Sousa, Natanael Teles Ramos de Lima, et al.
Current Drug Targets (2024) Vol. 25, Iss. 9, pp. 577-601
Closed Access
mRNA vaccines against arthropod-borne orthofaviviruses
Zuxin Wang, Hang Chi, Yong‐Qiang Deng, et al.
Chinese Science Bulletin (Chinese Version) (2024)
Closed Access
Research progress of mosquito-borne virus mRNA vaccines
Ning Sun, Zhiwei Su, Zheng Xiao-yan
Molecular Therapy — Methods & Clinical Development (2024) Vol. 33, Iss. 1, pp. 101398-101398
Open Access
Lipid Nanoparticle (LNP) Delivery Vector-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
(2023)
Open Access | Times Cited: 1
Research Progress in Nanopharmaceuticals with Different Delivery Routes in the Antivirus Field
Yenong Shi, Dongqiong He, Xianwei Zhang, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 25, pp. 1975-1991
Closed Access
Global Infectious Diseases in October 2022: Monthly Analysis
Yi Luo, Yinfu Sun, Wenjin Yu, et al.
Zoonoses (2022) Vol. 2, Iss. 1
Open Access
Page 1

Scroll to top